The global landscape of private non-profit expenditure on R&D in medical and health sciences shows Japan leading with significant investment, followed by Italy and South Korea, which experienced strong growth. Russia and Romania showed notable year-on-year increases, suggesting expanding interest in non-profit R&D. Conversely, countries like Chile, Taiwan, and Israel witnessed declines, indicating potential shifts in focus or financial constraints. Interestingly, Czech Republic and Romania displayed extraordinary growth, pointing to emerging R&D focus. Although smaller in scale, these nations' growth rates are noteworthy.
Future trends may include continued growth in Asian nations, with potential shifts in European R&D funding structures. Emerging economies like Romania could further increase their R&D investment, reshaping the landscape. Additionally, strategic changes in countries experiencing downturns might lead to stabilization or new R&D initiatives.
Top countries in Private Non-Profit Expenditure on R&D in Medical and Health Sciences Share by Country (Million US Dollars PPP)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Japan | 35.45 | 2023 | +1.49% | +5.99% | View data |
| 2 | 2 Italy | 26.94 | 2023 | +1.73% | +7.4% | View data |
| 3 | 3 South Korea | 25.88 | 2023 | +5.08% | +16.51% | View data |
| 4 | 4 Canada | 3.06 | 2023 | -2.99% | +3.84% | View data |
| 5 | 5 Spain | 3.04 | 2023 | +2.35% | +4.69% | View data |
| 6 | 6 Finland | 1.79 | 2023 | +1.26% | +2.52% | View data |
| 7 | 7 Russia | 1.11 | 2023 | +6.32% | +26.74% | View data |
| 8 | 8 Portugal | 1 | 2023 | +4.88% | +5.82% | View data |
| 9 | 9 Chile | 0.78 | 2023 | +0.77% | -3.04% | View data |
| 10 | 10 Taiwan | 0.35 | 2023 | -6.57% | -2.56% | View data |
